Andrew D. Reddick serves as Executive at ACURA PHARMACEUTICALS, INC, where they oversee executive responsibilities. Since joining the company, Andrew D. Reddick has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 4, 2011 involved selling 37,500 shares valued at $146.3K.
Andrew D. Reddick currently holds 1,067,609 shares of ACURA PHARMACEUTICALS, INC (ACUR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew D. Reddick has been a net neutral trader of ACUR stock. They have purchased $0 and sold $0 worth of shares.
Andrew D. Reddick's most recent insider trade was on Apr 4, 2011, when they sold 37,500 shares at $3.90 per share.
Get notified when new Form 4 filings are submitted
| $3.90 |
| Discretionary |
| Apr 4, 2011 | ACUR | $146.3K | Option Exercise | 112,500 | $1.30 | Discretionary |
| Jan 1, 2011 | ACUR | $308.0K | Payment | 93,038 | $3.31 | Discretionary |
| Nov 24, 2009 | ACUR | $509.7K | Payment | 119,658 | $4.26 | Discretionary |
| Nov 24, 2009 | ACUR | $552.5K | Payment | 129,695 | $4.26 | Discretionary |
| Nov 24, 2009 | ACUR | $552.5K | Option Exercise | 425,000 | $1.30 | Discretionary |
| Apr 24, 2009 | ACUR | $0 | Award | 85,000 | $N/A | Discretionary |